Your browser doesn't support javascript.
loading
Immunologic Features in De Novo and Recurrent Glioblastoma Are Associated with Survival Outcomes.
Alanio, Cécile; Binder, Zev A; Chang, Renee B; Nasrallah, MacLean P; Delman, Devora; Li, Joey H; Tang, Oliver Y; Zhang, Logan Y; Zhang, Jiasi Vicky; Wherry, E John; O'Rourke, Donald M; Beatty, Gregory L.
Afiliação
  • Alanio C; INSERM U932, PSL University, Institut Curie, Paris, France.
  • Binder ZA; Laboratoire d'immunologie clinique, Institut Curie, Paris, France.
  • Chang RB; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Nasrallah MP; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Delman D; Parker Institute for Cancer Immunotherapy at University of Pennsylvania, Philadelphia, Pennsylvania.
  • Li JH; Glioblastoma Translational Center of Excellence, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Tang OY; Glioblastoma Translational Center of Excellence, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Zhang LY; Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Zhang JV; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Wherry EJ; Glioblastoma Translational Center of Excellence, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • O'Rourke DM; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Beatty GL; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Cancer Immunol Res ; 10(7): 800-810, 2022 07 01.
Article em En | MEDLINE | ID: mdl-35507919
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França País de publicação: Estados Unidos